ClinicalTrials.Veeva

Menu

Multicenter Study Into Individualized Scanning for Coronary Artery Disease (MINDS-CAD)

Medical University of South Carolina (MUSC) logo

Medical University of South Carolina (MUSC)

Status

Completed

Conditions

Coronary Artery Disease

Treatments

Other: Differing Tube Voltage Administration

Study type

Observational

Funder types

Other

Identifiers

NCT04837846
00093255

Details and patient eligibility

About

To evaluate intravascular attenuation of the coronary arteries and image quality in an individualized scan and CM injection protocol whereas both scan and injection parameters are tailored to the individual patient in a North American, European and Asian patient population.

To evaluate the radiation dose and contrast media dose of this individualized approach for CCTA in an American, European and Chinese patient population.

To evaluate the injection parameters required for an average American, European and Chinese patient population.

Enrollment

60 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • To be eligible for the study: (All answers must be "YES" for subject to be eligible.)

    1. Referred for a clinically indicated CCTA scan.
    2. Patient aged older than 18.
    3. Subject must provide written informed consent prior to any study-related procedures being performed.
    4. Subject must be willing to comply with all clinical study procedures.
    5. Atypical or typical complaints of angina.
    6. No previous cardiovascular history.
    7. Possibility of 'flash' mode scan; patient heart rate below 70 beats per minute and regular rhythm.

Exclusion criteria

  • The presence of the following excludes subjects from the study: (All answers must be "NO" for subject to be eligible.)

    1. Contraindications for CT coronary angiography, including:

      1. Inability to perform a breath hold for at least the expected scan time
      2. Unstable angina
      3. Hemodynamic instability
      4. Known history of CAD
      5. Pregnancy
      6. Renal insufficiency (defined as Creatinine <1.5 mg/dL or GFR<30 mL/min)
      7. Iodine allergy
    2. Insufficient cannula venous access (preferred 18G, minimal 20G cannula)

    3. Subject has an acute psychiatric disorder.

    4. Subject is unwilling to comply with the requirements of the protocol.

    5. Subject has previously entered this study.

Trial design

60 participants in 1 patient group

Prospective CCTA Arm
Treatment:
Other: Differing Tube Voltage Administration

Trial contacts and locations

1

Loading...

Central trial contact

Vincent Giovagnoli, BS; Mark Ghent, BA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems